AI-Powered Healthcare: How ADLINK's Medical Innovations at HIMSS 2025 Are Transforming Patient Care
Celebrating 30 Years of Innovation Excellence with Advanced OEM Solutions for Healthcare
Summary:
Successful Showcase: ADLINK's latest AI-driven medical solutions attracted strong industry interest at HIMSS 2025
Engagement & Collaboration: Engaged with healthcare leaders, medical device manufacturers, and key industry partners
Technology Highlights: Demonstrated advanced medically certified UHD surgical monitors, NVIDIA IGX-powered computing, and high-performance medical box PCs
Long-Term Value: Reinforced commitment to extended lifecycle support, regulatory compliance, and strategic partnerships
LAS VEGAS, March 14, 2025 /PRNewswire/ -- As healthcare companies continue to seek cutting-edge solutions to enhance patient care, ADLINK Technology Inc. showcased its latest AI-powered medical innovations at HIMSS 2025, providing real-world applications that help medical professionals improve diagnostics, streamline workflows, and deliver better outcomes. With a focus on solving critical industry challenges, ADLINK's advanced OEM solutions are accelerating the adoption of AI in healthcare, driving efficiency, and enabling new treatment possibilities.
Addressing Healthcare's Biggest Challenges with AI
At HIMSS 2025, ADLINK demonstrated how its AI-driven technology is making a difference in real-world medical environments. From precision imaging in surgery to real-time AI inferencing for diagnostics, ADLINK's solutions are helping healthcare professionals optimize care delivery and improve decision-making. Key innovations on display included:
Medically Certified UHD Surgical Monitors: Delivered exceptional image reproduction and color accuracy for enhanced surgical precision.
Versatile All-in-One Medical Panel PCs: Designed for safety and compliance, meeting stringent EU Medical Device Regulation (MDR) standards.
MLB-IGX Medical Box PC: Leveraging NVIDIA IGX technology, providing ultra-fast, low-latency performance ideal for AI-driven real-time inferencing.
High-Performance Medical Box PCs: Engineered for advanced image processing, real-time data integration, and AI-powered surgical navigation.
Advanced GPU Solutions: Featuring NVIDIA RTX 2000 and RTX 5000 Lovelace Architecture for high-performance medical imaging applications.
Enabling Healthcare Innovation Through AI & Imaging
ADLINK's focus at HIMSS 2025 was on demonstrating tangible benefits for healthcare providers and device manufacturers. The company's FPGA-powered image processing and custom DICOM calibration are advancing imaging technology, ensuring precise diagnostics and faster patient assessments. Scalable embedded GPUs provide AI-driven insights, helping clinicians detect anomalies and make more informed decisions.
'Our technology is designed to solve real-world challenges in healthcare,' said Jacky Lin, VP of Business Development at ADLINK Technology. 'By leveraging AI and advanced imaging, we are enabling medical professionals to improve accuracy, efficiency, and patient outcomes.'
Collaborating for a Smarter Future in Healthcare
Throughout HIMSS 2025, ADLINK engaged with leading medical device manufacturers and healthcare organizations to discuss the future of AI-driven healthcare solutions. The company's strategic partnerships with Intel, NVIDIA, AMD, and NXP are fostering new developments in AI-powered diagnostics, automation, and patient care. These collaborations ensure that ADLINK's technology aligns with industry needs and regulatory requirements.
Beyond HIMSS 2025: The Future of AI in Healthcare
The strong reception at HIMSS 2025 underscores the growing demand for AI-integrated medical technology. ADLINK remains committed to partnering with healthcare innovators to deliver next-generation solutions that optimize workflows, enhance precision, and improve patient care. With an emphasis on long-term reliability and compliance, ADLINK's healthcare-focused solutions will continue to drive transformation in the industry.
For more information about ADLINK's healthcare solutions, visit ADLINK Healthcare.
About ADLINK Technology
ADLINK Technology Inc. is a global leader in edge computing. Our mission is to affect positive change in society and industry by connecting people, places and things with AI. The company offerings include robust boards, real-time data acquisition solutions and application enablement for AIoT. ADLINK serves customers in many industries, including healthcare, manufacturing, communications, transportation, defense, and aerospace.
ADLINK is a Premier Member of the Intel® Internet of Things Solutions Alliance, a partner of NVIDIA, and a contributor to standards initiatives such as Eclipse, OCP, OMG and ROS2 TSC. ADLINK is ISO-9001, ISO-14001, ISO-13485 and TL9000 certified and is publicly traded on TAIEX (Stock Code: 6166).
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
an hour ago
- Yahoo
Why Recursion Pharmaceuticals (RXRX) Soared On Friday
We recently published a list of . In this article, we are going to take a look at where Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) stands against other Friday's best-performing stocks. Recursion Pharmaceuticals grew its share prices by 20.13 percent on Friday to close at $5.49 apiece following the unveiling of Boltz-2, touted as the next-generation AI model to predict binding affinity. According to Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX), the new model is powered by its NVIDIA supercomputer for its training and validation, and represents the next step beyond existing biomolecular structure prediction models like AlphaFold3 and its predecessor, Boltz-1. A pharmacist in a hospital pharmacy stands next to a row of various drug containers. 'Selecting the right molecules early is one of the most fundamental challenges in drug discovery, with implications for whether R&D programs succeed or fail,' said Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) Chief Commercial Officer Najat Khan. 'By predicting both molecular structure and binding affinity simultaneously with unprecedented speed and scale, Boltz-2 gives R&D teams a powerful tool to triage more effectively and focus resources on the most promising compounds. Collaborations like this, bridging academic innovation and industry application, play an important role in advancing the field and, ultimately, improving how we develop and deliver medicines for patients,' she added. Overall, RXRX ranks 2nd on our list of Friday's best-performing stocks. While we acknowledge the potential of RXRX as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an extremely cheap AI stock that is also a major beneficiary of Trump tariffs and onshoring, see our free report on the best short-term AI stock. READ NEXT: 20 Best AI Stocks To Buy Now and 30 Best Stocks to Buy Now According to Billionaires. Disclosure: None. This article is originally published at Insider Monkey.
Yahoo
3 hours ago
- Yahoo
Why Costco Stock (COST) May Be a Smarter Investment Than Big Tech
Costco (COST) has long been a market favorite, but its current valuation has even the most bullish investors raising eyebrows as the company trades near all-time highs. Trading at earnings multiples that outpace some of the world's biggest tech giants, it's fair to ask: how can a warehouse selling pallets of toilet paper and rotisserie chickens possibly justify such a steep premium? At first glance, the numbers don't add up. Comparing Costco to tech companies indicates a rather inflated valuation for the wholesaler. Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter Timid growth projections, razor-thin margins, and a business model that hasn't changed much in decades don't exactly scream innovation. And yet, Costco continues to climb—largely, in my view, due to one key factor: risk perception. Because the company's business model is so heavily anchored in predictable, recurring revenue from membership fees, its earnings stream is exceptionally stable. That stability arguably justifies the stock's lofty valuation—and forms the backbone of my bullish thesis, even if there's little to no margin of safety. I agree with Costco's critics—those who are skeptical about a warehouse full of assorted goods trading at a forward P/E of 58, a multiple literally higher than tech giant and AI trailblazer Nvidia. For a company like Costco, which has grown revenue at a ~10% CAGR over the past five years and operating income by 15%—yet is only expected by analysts to grow revenue at a 5% CAGR over the next five—it really doesn't make much sense, at first glance, for the business to trade at such a steep premium. But here's what a lot of market participants miss when analyzing companies: valuations based on net earnings are heavily anchored to one key factor—risk. And unlike earnings, there's no single, universally accepted measure of risk. Some investors focus on beta, while others consider regulatory threats or macroeconomic exposure. Ultimately, each investor views the situation through their own lens. That's where Costco stands out as a rare case: a recurring revenue model outside of the tech sector. Customers pay an annual membership fee—ranging from $60 to $120 in the U.S.—just to shop in its warehouses. Costco likely converts nearly all of that directly into operating profit (though the company doesn't explicitly disclose this), which allows the business to be highly profitable even while selling goods at razor-thin margins. In the most recent quarter, membership income rose 10% year-over-year, with a staggering 93% renewal rate in North America. That kind of brand loyalty and perceived value creates a business model with very little risk of earnings volatility. And because of that, Costco functions like a defensive stock, offering low risk and a high degree of predictability in returns. So, while the valuation may look stretched on the surface, this level of stability and cash flow certainty arguably justifies a premium multiple. While only about 2% of Costco's total revenue comes from membership fees, those fees account for more than half of the company's total operating income. At this kind of scale, there's simply no other retailer that can pull off a high-volume, low-margin model quite like the Issaquah, Washington-based warehouse giant. Main Street Data indicates that Costco's revenues are inching higher while membership fees remain a staple. That's why, even during periods of weak consumer spending, Costco tends to remain highly profitable—not just because of its membership model, but because it consistently gains market share from competitors. By keeping margins razor-thin on discretionary items, and with shoppers naturally shifting toward essentials during times of financial stress, Costco puts pressure on rival retailers that simply can't match its pricing without cutting into their own profitability. Take Q3, for example: Costco's comparable sales rose 8% year-over-year to $62 billion, while peers like Target (TGT) saw comparable sales shrink and were forced to revise earnings guidance downward. This highlights how Costco isn't just weathering macroeconomic headwinds—it's actually growing through them. In other words, macro risks seem to have a much lighter impact on a company like Costco. While Costco's relatively low-risk business model may warrant a valuation premium, it's worth exploring what an appropriate stock price might look like under simplified assumptions. For this analysis, I'll estimate an equity value for Costco using a basic perpetuity-based discounted cash flow (DCF) model. Let's begin with the fact that, in fiscal year 2024, Costco generated approximately $4.8 billion in membership fee revenue. While this isn't equivalent to free cash flow, it serves as a reasonable proxy for recurring operating cash flow due to its stable and high-margin nature. With Costco's current market capitalization at approximately $470 billion, we can reverse-engineer the valuation. If we assume a 6% discount rate—reflecting the company's relatively low risk profile despite the 10-year Treasury yield sitting around 4.4%—and a perpetual growth rate of 5%, the implied equity value is approximately $480 billion, or about $1,083 per share. This closely aligns with Costco's current share price. These assumptions appear fairly reasonable and suggest that Costco's valuation is justified under optimistic, yet not unrealistic, conditions. However, using a more conservative 7% discount rate, while keeping other assumptions constant, would cut the implied equity value significantly, roughly in half. In summary, while Costco does not appear overvalued under favorable scenarios, the current valuation leaves little room for error. A meaningful margin of safety may only emerge if macroeconomic conditions shift, such as a recession prompting lower risk-free rates and, in turn, greater tolerance for elevated valuation multiples. Out of the 25 analysts who have covered COST in the past three months, 17 rate the stock as a Buy, while the remaining eight call it a Hold. So, while the overall sentiment is moderately bullish, the average price target of $1,096.36 implies ~8.5% upside from the current share price over the next twelve months. Given the strength and stability of Costco's underlying business model, its premium valuation multiples appear justifiable. At present, there are no significant concerns that would challenge a constructive outlook on the stock. However, it's important to note that the current valuation offers limited—if any—margin of safety. As such, I maintain a cautious Buy rating on Costco. While near-term upside may be constrained, the company remains well-positioned to deliver steady, long-term compound growth. Disclaimer & DisclosureReport an Issue
Yahoo
4 hours ago
- Yahoo
Prediction: This Artificial Intelligence (AI) Stock Could Hit a $6 Trillion Valuation by 2030
Nvidia is currently the world's largest company by market cap. The semiconductor giant still has a lot of room for growth, considering the potential investment in artificial intelligence (AI) infrastructure over the next five years. Nvidia has additional catalysts coming into play that could allow it to sustain terrific growth and hit a $6 trillion valuation in the future. 10 stocks we like better than Nvidia › Nvidia (NASDAQ: NVDA) is the most valuable company in the world as of this writing, with a market cap of $3.4 trillion, and it has reached this position thanks to a tremendous rally of more than 1,500% in its stock price in the past five years. Investors will now be wondering if Nvidia has the potential to deliver more upside over the next five years following this phenomenal run. However, don't be surprised to see this semiconductor giant's shares jump higher and attain a $6 trillion valuation by the end of the decade. Let's take a closer look at the factors that could help Nvidia hit that milestone by 2030. Robust demand for Nvidia's AI chips has been the biggest reason behind the stock's terrific surge in recent years. The good part is that Nvidia continues to generate a massive amount of revenue from its AI chip business despite tackling headwinds such as export restrictions to key markets like China. This was evident from Nvidia's latest results for the first quarter of fiscal 2026 (which ended on April 27). The company's revenue shot up 69% year over year to $44.1 billion during the quarter, even though it lost $2.5 billion in revenue in fiscal Q1, owing to the restrictions on sales of its chips to China. The chipmaker also incurred a $4.5 billion inventory charge to write down the value of chips that were intended for the Chinese market. Moreover, Nvidia's fiscal Q2 revenue would take an $8 billion hit on account of the China-related restrictions. But the good part is that the company's guidance for the current quarter still calls for a 50% year-over-year increase in revenue, while its earnings are expected to increase by 44% despite anticipated loss in Chinese revenue. CEO Jensen Huang admitted on Nvidia's latest earnings conference call that the $50 billion Chinese market is now effectively closed to U.S. players such as Nvidia. Even then, analysts have increased their revenue estimates. That's not surprising, as Nvidia still has a massive sales opportunity in AI chips beyond the Chinese market. It is now entering new markets such as Saudi Arabia to build AI factories "powered by several hundred thousand of Nvidia's most advanced GPUs over the next five years," according to the company. Additionally, massive AI infrastructure projects such as Stargate, from which Nvidia has started benefiting already, could help it mitigate the lost opportunity in China. Management consulting firm McKinsey & Company predicts that AI-capable data centers could require investments worth a whopping $5.2 trillion by 2030 to build enough computing power to handle training and inference workloads. So investors would do well to look past the China-related problems that Nvidia is currently facing, as the broader opportunity in the AI data center market should be lucrative enough to help the chipmaker keep growing at a healthy pace for the next five years. Moreover, Nvidia is showing no signs of losing its grip over the AI chip market. Its data center revenue shot up an impressive 73% year over year to $39 billion in the previous quarter. That was miles ahead of Broadcom's $4 billion AI revenue and AMD's $3.7 billion data center sales in the previous quarter, the two chipmakers that are considered to be the closest to Nvidia in the AI chip race. Nvidia's data center growth was higher than the 57% growth recorded by AMD in this segment and close to the 77% growth in Broadcom's AI revenue, even though it has a much larger revenue base. This is a testament to just how popular Nvidia's AI chips are, with the company's latest generation of Blackwell processors already a major hit among cloud computing giants within two quarters of hitting the market. Even better, Nvidia has moved past just selling AI hardware. It also offers access to models that help customers train and deploy AI agents, along with other enterprise AI applications that allow customers to improve the efficiency of their large language models (LLMs). Its enterprise platforms are gaining traction in diverse industries such as cybersecurity and restaurants where companies are deploying Nvidia's solutions to streamline their operations or to build agentic AI applications. All this indicates that investors shouldn't miss the forest for the trees, as Nvidia's long-term prospects aren't dependent on just China. There is still a lot of room for growth in the AI chip market, and the company's diversification into other areas such as enterprise AI applications and automotive should be enough to power remarkable growth over the next five years. Nvidia is currently trading at 23 times sales. While that's three times the U.S. technology sector's average price-to-sales ratio, the company's dominant position in AI chips, the prospects of this market, and the other catalysts that are coming into play help justify that valuation. We have already seen in the chart that Nvidia's top line is expected to jump to $292 billion in three years. If it maintains its sales multiple at that time, it will be able to easily surpass a $6 trillion valuation in just three years, representing a big jump from current levels. However, if we assume Nvidia's top-line growth slows after fiscal 2028 to an annual rate of 15% in fiscal 2029 and 2030 from the 31% compound annual growth rate that it is forecast to clock between fiscal 2026 and 2028 (using fiscal 2025 revenue of $130.5 billion as the base), its annual revenue could jump to $386 billion after five years. If Nvidia trades at a discounted 15 times sales at that time, it could still hit a $6 trillion valuation by 2030. So, investors can still consider buying this AI stock in anticipation of more upside in the long run, as it seems capable of maintaining its healthy growth rate over the next five years. Before you buy stock in Nvidia, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the for investors to buy now… and Nvidia wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years. Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you'd have $669,517!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you'd have $868,615!* Now, it's worth noting Stock Advisor's total average return is 792% — a market-crushing outperformance compared to 171% for the S&P 500. Don't miss out on the latest top 10 list, available when you join . See the 10 stocks » *Stock Advisor returns as of June 2, 2025 Harsh Chauhan has no position in any of the stocks mentioned. The Motley Fool has positions in and recommends Advanced Micro Devices and Nvidia. The Motley Fool recommends Broadcom. The Motley Fool has a disclosure policy. Prediction: This Artificial Intelligence (AI) Stock Could Hit a $6 Trillion Valuation by 2030 was originally published by The Motley Fool Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
